Table 3 Demographic, clinical, and laboratory data in diabetes and non-diabetes patients on peritoneal dialysis.
From: Predictors of outcomes in patients on peritoneal dialysis: A 2-year nationwide cohort study
Diabetes group | Non-diabetes group | P-value | |
|---|---|---|---|
Patients (n) | 3,319 | 5,635 | — |
Age (years) | 63.9 ± 11.8 | 61.9 ± 13.6 | <0.0001 |
Male sex (%) | 70.4 | 59.9 | <0.0001 |
PD duration (m) | 26 [13–48] | 37 [17–69] | <0.0001 |
Type 1 diabetes (%) | 8.3 | — | — |
Body mass index (kg/m2) | 24.3 ± 3.8 | 22.7 ± 3.6 | <0.0001 |
Smoking (%) | 9.9 | 6.9 | <0.0001 |
Antihypertensive agents (%) | 81.7 | 77.5 | <0.0001 |
Comorbid CVD (%) | 21.4 | 11.3 | <0.0001 |
Albumin (g/dL) | 3.2 ± 0.5 | 3.3 ± 0.5 | <0.0001 |
Non-HDL cholesterol (mg/dL) | 126 ± 38 | 130 ± 36 | 0.004 |
HDL cholesterol (mg/dL) | 46 ± 16 | 52 ± 17 | <0.0001 |
HbA1c (%) | 6.2 ± 1.1 | — | — |
C-reactive protein (mg/dL) | 0.17 [0.09–0.49] | 0.11 [0.06–0.37] | 0.001 |
Calcium (mg/dL) | 8.6 ± 0.8 | 8.8 ± 0.8 | <0.0001 |
Phosphate (mg/dL) | 5.2 ± 1.3 | 5.3 ± 1.3 | 0.028 |
Intact PTH (pg/mL) | 150 [77–249] | 158 [82–267] | 0.002 |
Hemoglobin (g/dL) | 10.8 ± 1.4 | 10.8 ± 1.4 | 0.313 |
Renal Kt/V | 0.4 [0–0.9] | 0.2 [0–0.7] | <0.0001 |
PD Kt/V | 1.3 ± 0.6 | 1.4 ± 0.6 | <0.0001 |
Total Kt/V | 1.8 ± 0.8 | 1.8 ± 0.8 | 0.848 |
D/P Cr | 0.67 ± 0.13 | 0.64 ± 0.13 | <0.0001 |
PET category (%) | <0.0001 | ||
Low | 8.1 | 11.6 | |
Low average | 36.7 | 39.1 | |
High average | 42.1 | 40.5 | |
High | 13.1 | 8.8 | |
Use of 2.5% glucose dialysate (%) | 40.1 | 36.0 | 0.002 |
Use of icodextrin (%) | 45.0 | 38.3 | <0.0001 |
Use of APD system (%) | 43.3 | 43.1 | 0.924 |
Connecting system (%) | |||
Device (+) | 72.5 | 65.5 | <0.001 |
PD + HD combination (%) | 18.5 | 19.0 | 0.537 |
